Evolent to Purchase Vital Decisions in $85 Million Deal

Evolent Health (NYSE: EVH) has penned a definitive agreement to buy Vital Decisions from its current private equity owners WindRose Health Investors for $85 million. The deal also includes an additional earn out of $45 million. Vital Decisions offers telehealth solutions to support advance care planning.

An “earn out” in an acquisition refers to additional funds a seller receives after the purchased company achieves certain performance targets. After the deal closes, Vital Decisions will report into Evolent’s especially management business, New Century Health, and will be consolidated into the company’s Clinical Solutions segment. 

“Cancer and heart disease account for more than 50% of deaths in the United States and drive a substantial portion of health care services at the end of life,” said New Century Health CEO Dan McCarthy. “The addition of Vital Decisions to New Century Health will help ensure that the care plans for these and other individuals facing advanced illness align with their core values and personal preferences.” 

Advertisement

Evolent offers services to assist health plans and providers across the continuum to build the necessary operational scale and clinical performance to work successfully in value-based payment models. The company’s New Century Health subsidiary is focused on improving oncology and cardiology outcomes through peer-led provider collaboration. 

The combining of these two company’s reflect two growing priorities in the health care sector: advance care planning and telehealth.

Advance care plans are a key tool in ensuring that patient choices are known and honored during the course of their serious or terminal illnesses. Incentivizing advance care planning discussions to place a greater emphasis has been correlated to improved outcomes. Such discussions about patient’s end-of-life goals and wishes have been associated with improved access to quality of care, increased hospice utilization and longer life expectancy.

Advertisement

Only 1 in 3 people in the United States have had discussions with clinicians and loved ones about their end-of-life wishes, even though about 92% had said they believe such conversations are important, according to a 2018 survey by the Conversation Project. Fewer than 40% of those who suffer from a serious illness have an advance directive, the survey found.

In recent years, a cottage industry has sprung up around advance care planning services, and a number of the emerging value-based payment models newly available to hospices have elements designed to encourage more patients to document their end-of-life wishes.

Expansion of telehealth services across the health care continuum accelerated rapidly due to efforts to stem the spread of the novel coronavirus. Telehealth visits have helped providers maintain continuity of care while limiting in-person contact. These developments will likely shape health care for years to come including for hospice and palliative care providers.

The U.S. Centers for Medicare & Medicaid Services (CMS) has indicated that it will be making permanent a number of the temporary flexibilities to expand telehealth that the agency implemented in response to the COVID-19 pandemic. However, the number of rules affecting hospices that would be extended remains to be seen.

“From its inception, the vision of Vital Decisions has been to facilitate higher levels of alignment among patients, their family, and their providers regarding the care that is delivered during an advanced illness,” Vital Decisions Co-Founder and Executive Chairman Mitchell Daitz added. “Leveraging New Century Health’s expertise in provider relationship management will accelerate the organization’s progress towards that goal.”

Companies featured in this article:

,